<http://schema.org/url>
<https://www.genengnews.com/>
<http://www.genengnews.com/keywordsandtools/email/gen-news-highlights/bayer-plans-2012-filing-for-regorafenib-following-positive-phase-iii-mcrc-trial-results/25733/>